DE60031096D1 - Auf der dreidimensionalen struktur von lta4 hydrolase basierender entwurf von arzneimitteln - Google Patents

Auf der dreidimensionalen struktur von lta4 hydrolase basierender entwurf von arzneimitteln

Info

Publication number
DE60031096D1
DE60031096D1 DE60031096T DE60031096T DE60031096D1 DE 60031096 D1 DE60031096 D1 DE 60031096D1 DE 60031096 T DE60031096 T DE 60031096T DE 60031096 T DE60031096 T DE 60031096T DE 60031096 D1 DE60031096 D1 DE 60031096D1
Authority
DE
Germany
Prior art keywords
lta4
hydrolase
dimensional structure
present
lta4 hydrolase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60031096T
Other languages
English (en)
Other versions
DE60031096T2 (de
Inventor
Jesper Z Haeggstroem
Paer Nordlund
Marjolein Thunissen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardoz AB
Original Assignee
HAEEGGSTROEM JESPER Z
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9900722A external-priority patent/SE9900722D0/xx
Application filed by HAEEGGSTROEM JESPER Z filed Critical HAEEGGSTROEM JESPER Z
Publication of DE60031096D1 publication Critical patent/DE60031096D1/de
Application granted granted Critical
Publication of DE60031096T2 publication Critical patent/DE60031096T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60031096T 1999-02-26 2000-02-28 Auf der dreidimensionalen struktur von lta4 hydrolase basierender entwurf von arzneimitteln Expired - Lifetime DE60031096T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12211099P 1999-02-26 1999-02-26
SE9900722 1999-02-26
US122110P 1999-02-26
SE9900722A SE9900722D0 (sv) 1999-02-26 1999-02-26 Drug design based on the structure of LTA4 hydrolase
PCT/SE2000/000384 WO2000050577A1 (en) 1999-02-26 2000-02-28 Drug design based on the structure of lta4 hydrolase

Publications (2)

Publication Number Publication Date
DE60031096D1 true DE60031096D1 (de) 2006-11-16
DE60031096T2 DE60031096T2 (de) 2007-05-10

Family

ID=26663520

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60031096T Expired - Lifetime DE60031096T2 (de) 1999-02-26 2000-02-28 Auf der dreidimensionalen struktur von lta4 hydrolase basierender entwurf von arzneimitteln

Country Status (6)

Country Link
US (1) US7590494B1 (de)
EP (1) EP1157101B1 (de)
AT (1) ATE341615T1 (de)
AU (1) AU3468300A (de)
DE (1) DE60031096T2 (de)
WO (1) WO2000050577A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7851486B2 (en) 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
US7507531B2 (en) 2002-10-17 2009-03-24 Decode Genetics Chf. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
MX2016008247A (es) 2013-12-20 2016-10-21 Novartis Ag Derivados de acido heteroaril butanoico como inhibidores de lta4h.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5331573A (en) * 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
US20040137518A1 (en) * 2002-01-31 2004-07-15 Lambert Millard Hurst CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAME

Also Published As

Publication number Publication date
AU3468300A (en) 2000-09-14
ATE341615T1 (de) 2006-10-15
US7590494B1 (en) 2009-09-15
WO2000050577A1 (en) 2000-08-31
EP1157101B1 (de) 2006-10-04
EP1157101A1 (de) 2001-11-28
DE60031096T2 (de) 2007-05-10

Similar Documents

Publication Publication Date Title
DE69824075D1 (de) Informationsverarbeitungssystem, rechnerlesbare Medien, und Entwurfsystem
Amano et al. Implications of different definitions and generic issues
DE69831708D1 (de) Effiziente Erkennung von Computerviren und andere Dateneigenschaften
DE60026456D1 (de) Spielsystem und computerlesbares Aufzeichungsmedium
DE69940031D1 (de) Merging von computer-partitionen
TR200102876T2 (tr) Bileşim tedavilerinde CYP2D6 önleyicilerinin kullanılması.
DE60039743D1 (de) Spielsystem und computerlesbares Aufzeichnungsmedium
DE60045135D1 (de) Kodierung eines Informationssignals in mehreren Raten
ITTO990870A0 (it) Pallet, sistema e procedimento da utilizzare per testare e/o installar e software su una unita' di sistema di elaboratore personale.
UY25712A1 (es) Benzamidas sustituidas y su aplicación en medicamentos
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
HUP0004415A2 (hu) Kimutatási rendszerek a fehérjék közötti kölcsönhatások, illetve funkcionális kapcsolatok regisztrálására
ATE322667T1 (de) Winkelmesssystem
BR0316493A (pt) ésteres de ácido aldÈnico, métodos para produzir os mesmos, e métodos para produzir ingredientes ativos farmacêuticos ligados a polissacarìdicos ou derivados polissacarìdeos sobre grupos amino livres
DE60031096D1 (de) Auf der dreidimensionalen struktur von lta4 hydrolase basierender entwurf von arzneimitteln
DE69904618D1 (de) Detektionstechnik von speicherabschnittfehlern und einzel-, doppel und triplebitfehlern
DK1392522T3 (da) Indretning med skriveflade
DE122011100041I1 (de) In vitro-rekonstitution von segmentierten, negativstrang-rna-viren.
Correll et al. Nonpainful, erythematous, circinate lesions of a protean nature on a fissured tongue.
MA27172A1 (fr) 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments
FI19992449A (fi) Tietojen käsittely ajanseurannassa
IT248996Y1 (it) Prodotto editoriale e di cartoleria, quale agenda, quaderno, libro,rivista, giornale, raccoglitore,ecc.,con particolari caratteristiche
Hart Verbicide.
CY1106311T1 (el) Χορηγηση απο το στομα παραγωγων ταξοειδων
WO2000048466A3 (en) Protease inhibitors that overcome drug resistance

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: CARDOZ AB, STOCKHOLM, SE

8328 Change in the person/name/address of the agent

Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, 80539

8364 No opposition during term of opposition